Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Recruiting · NCT06803875 · Registry updated 2025-12-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 / Phase 2 | 2025-12-26 | NCT06803875 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Children's Hospital | 238 |
| Dana-Farber Cancer Institute | 324 |
| Roberto Chiarle | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Dana-Farber Cancer Institute | Boston | United States | 68 |